Literature DB >> 15133843

Construction of human liver cancer vascular endothelium cDNA expression library and screening of the endothelium-associated antigen genes.

Xing Zhong1, Yu-Liang Ran, Jin-Ning Lou, Dong Hu, Long Yu, Yu-Shan Zhang, Zhuan Zhou, Zhi-Hua Yang.   

Abstract

AIM: To gain tumor endothelium associated antigen genes from human liver cancer vascular endothelial cells (HLCVECs) cDNA expression library, so as to find some new possible targets for the diagnosis and therapy of liver tumor.
METHODS: HLCVECs were isolated and purified from a fresh hepatocellular carcinoma tissue sample, and were cultured and proliferated in vitro. A cDNA expression library was constructed with the mRNA extracted from HLCVECs. Anti-sera were prepared from immunized BALB/c mice through subcutaneous injection with high dose of fixed HLCVECs, and were then tested for their specificity against HLCVECs and angiogenic effects in vitro, such as inhibiting proliferation and inducing apoptosis of tumor endothelial cells, using immunocytochemistry, immunofluorescence, cell cycle analysis and MTT assays, etc. The identified xenogeneic sera from immunized mice were employed to screen the library of HLCVECs by modified serological analyses of recombinant cDNA expression libraries (SEREX). The positive clones were sequenced and analyzed by bio-informatics.
RESULTS: The primary cDNA library consisted of 2 x 10(6) recombinants. Thirty-six positive clones were obtained from 6 x 10(5) independent clones by immunoscreening. Bio-informatics analysis of cDNA sequences indicated that 36 positive clones represented 18 different genes. Among them, 3 were new genes previously unreported, 2 of which were hypothetical genes. The other 15 were already known ones. Series analysis of gene expression (SAGE) database showed that ERP70, GRP58, GAPDH, SSB, S100A6, BMP-6, DVS27, HSP70 and NAC alpha in these genes were associated with endothelium and angiogenesis, but their effects on HLCVECs were still unclear. GAPDH, S100A6, BMP-6 and hsp70 were identified by SEREX in other tumor cDNA expression libraries.
CONCLUSION: By screening of HLCVECs cDNA expression library using sera from immunized mice with HLCVECs, the functional genes associated with tumor endothelium or angiogenesis were identified. The modified SEREX, xenogeneic functional serum screening, was demonstrated to be effective for isolation and identification of antigen genes of tumor endothelium, and also for other tumor cell antigen genes. These antigen genes obtained in this study could be a valuable resource for basic and clinical studies of tumor angiogenesis, thus facilitating the development of anti- angiogenesis targeting therapy of tumors.

Entities:  

Mesh:

Year:  2004        PMID: 15133843      PMCID: PMC4656274          DOI: 10.3748/wjg.v10.i10.1402

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Genes expressed in human tumor endothelium.

Authors:  B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

2.  Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.

Authors:  T Ono; S Sato; N Kimura; M Tanaka; A Shibuya; L J Old; E Nakayama
Journal:  Int J Cancer       Date:  2000-12-15       Impact factor: 7.396

Review 3.  Cancer vaccine: identification of human tumor antigens by SEREX.

Authors:  Y T Chen
Journal:  Cancer J       Date:  2000-05       Impact factor: 3.360

4.  Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours.

Authors:  I Camby; F Lefranc; G Titeca; S Neuci; M Fastrez; L Dedecken; B W Schäfer; J Brotchi; C W Heizmann; R Pochet; I Salmon; R Kiss; C Decaestecker
Journal:  Neuropathol Appl Neurobiol       Date:  2000-02       Impact factor: 8.090

Review 5.  Angiogenesis inhibitors generated by tumors.

Authors:  J Folkman
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

6.  Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells.

Authors:  G Alessandri; R G Chirivi; S Fiorentini; R Dossi; S Bonardelli; S M Giulini; G Zanetta; F Landoni; P P Graziotti; A Turano; A Caruso; L Zardi; R Giavazzi; M R Bani
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

7.  Openings between defective endothelial cells explain tumor vessel leakiness.

Authors:  H Hashizume; P Baluk; S Morikawa; J W McLean; G Thurston; S Roberge; R K Jain; D M McDonald
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

8.  Inhibition of leukocyte adherence and transendothelial migration in cultured human liver vascular endothelial cells by prostaglandin E1.

Authors:  J Lou; L Bühler; S Deng; G Mentha; R Montesano; G E Grau; P Morel
Journal:  Hepatology       Date:  1998-03       Impact factor: 17.425

9.  Identification of a novel endothelial-derived gene EG-1.

Authors:  Canhui Liu; Liping Zhang; Zhi-Ming Shao; Perrin Beatty; Maryam Sartippour; Timothy F Lane; Sanford H Barsky; Edward Livingston; Mai Nguyen
Journal:  Biochem Biophys Res Commun       Date:  2002-01-11       Impact factor: 3.575

10.  Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice.

Authors:  F A Scappaticci; A Contreras; C A Boswell; J S Lewis; G Nolan
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

View more
  3 in total

1.  Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy.

Authors:  Juhua Zhou; Mark E Dudley; Steven A Rosenberg; Paul F Robbins
Journal:  J Immunother       Date:  2005 Jan-Feb       Impact factor: 4.456

2.  Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens.

Authors:  René Stempfer; Parvez Syed; Klemens Vierlinger; Rudolf Pichler; Eckart Meese; Petra Leidinger; Nicole Ludwig; Albert Kriegner; Christa Nöhammer; Andreas Weinhäusel
Journal:  BMC Cancer       Date:  2010-11-16       Impact factor: 4.430

3.  A novel model for evaluating therapies targeting human tumor vasculature and human cancer stem-like cells.

Authors:  Daniela Burgos-Ojeda; Karen McLean; Shoumei Bai; Heather Pulaski; Yusong Gong; Ines Silva; Karl Skorecki; Maty Tzukerman; Ronald J Buckanovich
Journal:  Cancer Res       Date:  2013-04-10       Impact factor: 12.701

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.